The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Cholestasis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Cholestasis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Cholestasis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Cholestasis pipeline landscape. The report p...
April 2021
30 pages
Chordoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Chordoma (Oncology) - Drugs in Development, 2021 SUMMARY Chordoma (Oncology) - Drugs in Development, 2021 provides an overview of the Chordoma pipeline landscape. The report provides comprehensive inf...
April 2021
55 pages
Choroideremia (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Choroideremia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Choroideremia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Choroideremia pipeline landscape. The report p...
April 2021
30 pages
Chronic Cough (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Chronic Cough (Respiratory) - Drugs in Development, 2021 SUMMARY Chronic Cough (Respiratory) - Drugs in Development, 2021 provides an overview of the Chronic Cough pipeline landscape. The report provi...
April 2021
40 pages
Cirrhosis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Cirrhosis pipeline landscape. The report provide...
April 2021
35 pages
Claudin 18 (CLDN18) - Drugs in Development, 2021
US$ 3,000.00
Claudin 18 (CLDN18) - Drugs in Development, 2021 SUMMARY Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (CLDN18) targeted pipeline therapeutics. The report p...
April 2021
35 pages
CNS Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
CNS Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY CNS Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the CNS Lymphoma pipeline landscape. The report provides compr...
April 2021
30 pages
Colon Carcinoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Colon Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Colon Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Colon Carcinoma pipeline landscape. The report provi...
April 2021
75 pages
